Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYSLTR2 | Q9NS75 | 16/20 | 0.47 |
| ▸ | CYSLTR1 | Q9Y271 | 16/20 | 0.47 |
| ▸ | PPARG | P37231 | 2/20 | 0.43 |
| ▸ | PPARD | Q03181 | 2/20 | 0.43 |
| ▸ | PPARA | Q07869 | 2/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.43 |
| ▸ | BLM | P54132 | 1/20 | 0.43 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.43 |
| ▸ | PRKCI | P41743 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9178239 | 0.88 | CYSLTR2 (0.44) | CYSLTR2CYSLTR1PPARGPPARDPPARA | |
| SCHEMBL9175493 | 0.83 | HTT (0.40) | CYSLTR2CYSLTR1MAPT | |
| SCHEMBL9177662 | 0.83 | CYSLTR2 (0.50) | CYSLTR2CYSLTR1PPARGPPARDPPARA | |
| SCHEMBL9178362 | 0.82 | CTSD (0.46) | CYSLTR2CYSLTR1LMNAMAPT | |
| SCHEMBL7968145 | 0.81 | CYSLTR2 (0.49) | CYSLTR2CYSLTR1PPARGPPARDPPARA | |
| SCHEMBL9174003 | 0.81 | CYSLTR2 (0.49) | CYSLTR2CYSLTR1PPARGPPARDPPARA | |
| SCHEMBL9176938 | 0.81 | CYSLTR2 (0.45) | CYSLTR2CYSLTR1CYP1A2MAPTCYP2C9 | |
| SCHEMBL9734780 | 0.78 | CYSLTR2 (0.46) | CYSLTR2CYSLTR1PPARGPPARDPPARA | |
| SCHEMBL9179085 | 0.78 | MAPT (0.43) | CYSLTR2CYSLTR1CYP1A2MAPTCYP2C9 | |
| SCHEMBL30736074 | 0.77 | CYP1A2 (0.50) | CYSLTR2CYSLTR1PPARGPPARDPPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5105017-A | Antiallergens | ELI LILLY AND COMPANY (US) | 1992-04-14 | — | — | US | claimed |
| US-6251928-B1 | ADMINISTERING BENZYLIDENE RHODANINES WHICH ARE USEFUL AS AGENTS IN TREATING OR PREVENTING CONDITIONS ASSOCIATED WITH BETA-AMYLOID PEPTIDE IN A MAMMAL | ELI LILLY AND COMPANY | 2001-06-26 | — | — | US | disclosed |
| US-5747517-A | ALZHEIMER'S DISEASE; PROTEASE INHIBITORS | ELI LILLY AND COMPANY (US) | 1998-05-05 | — | — | US | disclosed |
| EP-0677517-A1 | Treatment of Alzheimer's disease employing inhibitors of cathepsin D | ELI LILLY AND COMPANY (US) | 1995-10-18 | — | — | EP | disclosed |
| US-5393768-A | Treating hypersensitivity reactions such as asthma | ELI LILLY AND COMPANY (US) | 1995-02-28 | — | — | US | disclosed |
| US-5105017-A | Antiallergens | ELI LILLY AND COMPANY (US) | 1992-04-14 | — | — | US | disclosed |
| EP-0132366-B1 | LEUKOTRIENE ANTAGONISTS | ELI LILLY AND COMPANY (US) | 1990-01-03 | — | — | EP | disclosed |
| EP-0132366-A2 | Leukotriene antagonists | ELI LILLY AND COMPANY (US) | 1985-01-30 | — | — | EP | disclosed |